Trials / Completed
CompletedNCT05671172
Effect of Adding Hyaluronidase to Bupivacaine in Transversus Abdominis Plane Block for Cesarean Section
Effect of Adding Two Different Doses of Hyaluronidase to Bupivacaine in Ultrasound-Guided Transversus Abdominis Plane (TAP) Block for Post-cesarean Section Analgesia; A Randomized Controlled Double Blinded Study.
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 114 (actual)
- Sponsor
- Benha University · Academic / Other
- Sex
- Female
- Age
- 18 Years – 40 Years
- Healthy volunteers
- Not accepted
Summary
Since TAP block needs to affect several nerves in single tissue plane with a single prick, hyaluronidase is expected to aid greatly in the spread of the LA and help the block. However, there have not been adequate studies to establish the efficacy of adding hyaluronidase in lateral TAP after cesarean section. Hence, the present study was carried out to evaluate the efficacy of hyaluronidase in different concentrations added to bupivacaine in US-guided bilateral lateral TAP block.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Hyaluronidase | hyaluronidase will be applied as adjuvant to bupivacaine in transversus abdominis plane block to enhance the postoperative analgesic effect after CS |
| DRUG | Bupivacaine Injection | 20ml bupivacaine will be injected without additives in the transversus abdominis plane block on each side for postoperative analgesic after CS |
Timeline
- Start date
- 2023-05-15
- Primary completion
- 2024-01-10
- Completion
- 2024-02-10
- First posted
- 2023-01-04
- Last updated
- 2025-09-19
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT05671172. Inclusion in this directory is not an endorsement.